Plasma IL‐6, plasma VEGF, and serum YKL‐40: relationship with disease activity and radiographic progression in rheumatoid arthritis patients treated with infliximab and methotrexate
- 1 January 2006
- journal article
- other
- Published by Taylor & Francis in Scandinavian Journal of Rheumatology
- Vol. 35 (6) , 489-491
Abstract
(2006). Plasma IL‐6, plasma VEGF, and serum YKL‐40: relationship with disease activity and radiographic progression in rheumatoid arthritis patients treated with infliximab and methotrexate. Scandinavian Journal of Rheumatology: Vol. 35, No. 6, pp. 489-491.Keywords
This publication has 9 references indexed in Scilit:
- Inflammatory Cytokines Induce Production of CHI3L1 by Articular ChondrocytesJournal of Biological Chemistry, 2005
- Angiogenesis in rheumatoid arthritisArthritis Research & Therapy, 2002
- The paradigm of IL-6: from basic science to medicineArthritis Research & Therapy, 2002
- Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritisArthritis & Rheumatism, 2001
- Cytokines, metalloproteinases, their inhibitors and cartilage oligomeric matrix protein: relationship to radiological progression and inflammation in early rheumatoid arthritis. A prospective 5-year studyRheumatology, 2001
- Regulation of Cytokines, Cytokine Inhibitors, and Acute-Phase Proteins Following Anti-TNF-α Therapy in Rheumatoid ArthritisThe Journal of Immunology, 1999
- Serum YKL-40 concentrations in patients with rheumatoid arthritis: relation to disease activityRheumatology, 1999
- Development and validation of the european league against rheumatism response criteria for rheumatoid arthritis: Comparison with the preliminary american college of rheumatology and the world health organization/international league against rheumatism criteriaArthritis & Rheumatism, 1996
- How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis?Arthritis & Rheumatism, 1985